Development and Statistical Analysis of Glipzide-Loaded Fast-Dissolving Tablets Using Plantago ovata Husk as a Superdisintegrant
Download in electronic PDF format for $65
Abstract: The purpose of this study was to develop fast dissolving tablets of glipizide, a sulfonylurea antidiabetic drug. Powder blends containing pregelatinized Plantago ovata husk, microcrystalline cellulose, and starch (soluble) were converted into tablets by the direct compression method. The tablets were evaluated for disintegration time, hardness, percentage friability, drug entrapment efficiency, and content uniformity tests. In the investigation, a 32 full factorial design was used to investigate the joint influence of two formulation variables: (1) amount of pregelatinized Plantago ovata husk and (2) compression force. The results of multiple linear regression analysis revealed that for obtaining a fast-dissolving dosage form, tablets should be prepared using a higher concentration of pregelatinized Plantago ovata husk and an optimum level of compression force. A contour plot is also presented to graphically represent the effect of the independent variables on the disintegration time and percentage friability.
Related Keywords:
Astesh Kr Jha, M Pharm, D. Chetia, PhD, fast-dissolving tablets, glipizide, mucilage, Plantago ovata husk, disintegration time, content uniformity test, drug entrapment efficiency test, hardness, friability, superdisintegrant, compression
Related Categories:
DIABETES, EXCIPIENTS, PEER-REVIEWED, QUALITY CONTROL, DOSAGE FORMS/DRUG CARRIERS
Printer-Friendly Version
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Development and Statistical Analysis of Glipzide-Loaded Fast-Dissolving Tablets Using Plantago ovata Husk as a Superdisintegrant
Jha Antesh Kr, Chetia D
|
Nov/Dec 2011
Pg. 521-525
|
Quality Control Analytical Methods: End-preparation Assessments and Tests for Compounded Sterile Preparations
McElhiney Linda F
|
Jul/Aug 2013
Pg. 307-311
|
Quality Control: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 2
Vu Nicole, Lou Jessica R, Kupiec Thomas C
|
Jul/Aug 2014
Pg. 305-310
|
Comparison of Disintegrant-addition Methods on the Compounding of Orodispersible Tablets
Mahesparan Vishnu A/L, Bin Abd Razak Fashli Syafiq, Ming Long Chiau, Uddin ABM Helal, Sarker Md Zaidul Islam, Bin Liew Kai
|
Mar/Apr 2020
Pg. 148-155
|
Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 491-496
|
Molding as Innovative Technology for Personalized Tablet Production
Mady Omar Y, Al-Shoubki Adam A, Hagag Youssef, Ibrahim Bakry, Donia Ahmed A
|
Mar/Apr 2022
Pg. 163-174
|
Quality Control: Rapid Sterility Testing for Compounding Pharmacies
Taylor Andrew
|
Jul/Aug 2020
Pg. 299-303
|
Microbiologic Testing for 503A Sterile-Compounding Pharmacies
Mixon William, Roth Abby
|
May/Jun 2017
Pg. 193-203
|
Summary of Quality-Control Testing for Sterile and Nonsterile Compounded Preparations, Part 2: Microbiological Testing
Allen Loyd V Jr
|
Jul/Aug 2019
Pg. 299-303
|
Application of Co-processed Excipient as a Novel Method to Compound Orally Disintegrating Tablets
Liew Kai Bin, Hii Shou Hui, Chew Yik Ling, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam
|
May/Jun 2022
Pg. 255-263
|